Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain (Q38669012)

5 September 2017

Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain (English)

1 reference

5 September 2017

0 references

Celeste B Burness

1

1 reference

PubMed ID

26666418

5 September 2017

Paul L McCormack

series ordinal

2

1 reference

5 September 2017

14 December 2015

1 reference

5 September 2017

1 reference

5 September 2017

76

1 reference

5 September 2017

1

1 reference

5 September 2017

123-134

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-015-0520-9

5 September 2017

0 references

cites work

Neuropathic pain: redefinition and a grading system for clinical and research purposes

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

NeuPSIG guidelines on neuropathic pain assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

From benzodiazepine to pregabalin dependence: Different agents, similar problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Capsaicin for neuropathic pain: linking traditional medicine and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Cutaneous drug delivery of capsaicin after in vitro administration of the 8% capsaicin dermal patch system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world' clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0520-9

A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26666418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cost-Effectiveness of Capsaicin 8% Patch (Qutenza(tm)) Compared With Pregabalin for the Treatment of Patients With Peripheral Neuropathic Pain (Pnp) In Scotland

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26666418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26666418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40265-015-0520-9

1 reference

PubMed ID

26666418

Dimensions Publication ID

5 September 2017

0 references

1 reference

PubMed ID

26666418